255 related articles for article (PubMed ID: 22393708)
1. [Progress in improvement of lentiviral vectors' transcriptional read-through].
He J; Zhang J
Sheng Wu Gong Cheng Xue Bao; 2011 Nov; 27(11):1541-8. PubMed ID: 22393708
[TBL] [Abstract][Full Text] [Related]
2. Risk assessment in skin gene therapy: viral-cellular fusion transcripts generated by proviral transcriptional read-through in keratinocytes transduced with self-inactivating lentiviral vectors.
Almarza D; Bussadori G; Navarro M; Mavilio F; Larcher F; Murillas R
Gene Ther; 2011 Jul; 18(7):674-81. PubMed ID: 21368897
[TBL] [Abstract][Full Text] [Related]
3. Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors.
Schambach A; Galla M; Maetzig T; Loew R; Baum C
Mol Ther; 2007 Jun; 15(6):1167-73. PubMed ID: 17406345
[TBL] [Abstract][Full Text] [Related]
4. Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo.
Céfaï D; Simeoni E; Ludunge KM; Driscoll R; von Segesser LK; Kappenberger L; Vassalli G
J Mol Cell Cardiol; 2005 Feb; 38(2):333-44. PubMed ID: 15698840
[TBL] [Abstract][Full Text] [Related]
5. Gene transfer in ovarian cancer cells: a comparison between retroviral and lentiviral vectors.
Indraccolo S; Habeler W; Tisato V; Stievano L; Piovan E; Tosello V; Esposito G; Wagner R; Uberla K; Chieco-Bianchi L; Amadori A
Cancer Res; 2002 Nov; 62(21):6099-107. PubMed ID: 12414634
[TBL] [Abstract][Full Text] [Related]
6. A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells.
Zhou S; Mody D; DeRavin SS; Hauer J; Lu T; Ma Z; Hacein-Bey Abina S; Gray JT; Greene MR; Cavazzana-Calvo M; Malech HL; Sorrentino BP
Blood; 2010 Aug; 116(6):900-8. PubMed ID: 20457870
[TBL] [Abstract][Full Text] [Related]
7. Comparison of gene-trapping efficiency between retroviral and lentiviral vectors in mouse embryonic stem cells.
Yamaguchi T; Morikawa A; Miyoshi H
Biochem Biophys Res Commun; 2012 Aug; 425(2):297-303. PubMed ID: 22842569
[TBL] [Abstract][Full Text] [Related]
8. Self-inactivating lentiviral vectors with U3 and U5 modifications.
Iwakuma T; Cui Y; Chang LJ
Virology; 1999 Aug; 261(1):120-32. PubMed ID: 10441560
[TBL] [Abstract][Full Text] [Related]
9. Understanding lentiviral vector chromatin targeting: working to reduce insertional mutagenic potential for gene therapy.
Papayannakos C; Daniel R
Gene Ther; 2013 Jun; 20(6):581-8. PubMed ID: 23171920
[TBL] [Abstract][Full Text] [Related]
10. Activity analysis of housekeeping promoters using self-inactivating lentiviral vector delivery into the mouse retina.
Kostic C; Chiodini F; Salmon P; Wiznerowicz M; Deglon N; Hornfeld D; Trono D; Aebischer P; Schorderet DF; Munier FL; Arsenijevic Y
Gene Ther; 2003 May; 10(9):818-21. PubMed ID: 12704422
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector.
Lavenu-Bombled C; Izac B; Legrand F; Cambot M; Vigier A; Massé JM; Dubart-Kupperschmitt A
Stem Cells; 2007 Jun; 25(6):1571-7. PubMed ID: 17379771
[TBL] [Abstract][Full Text] [Related]
12. Improvement of lentiviral transfer vectors using cis-acting regulatory elements for increased gene expression.
Real G; Monteiro F; Burger C; Alves PM
Appl Microbiol Biotechnol; 2011 Sep; 91(6):1581-91. PubMed ID: 21674167
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of lentiviral vectors harboring the proximal promoter of the vav proto-oncogene: a weak and efficient promoter for gene therapy.
Almarza E; Río P; Meza NW; Aldea M; Agirre X; Guenechea G; Segovia JC; Bueren JA
Mol Ther; 2007 Aug; 15(8):1487-94. PubMed ID: 17534266
[TBL] [Abstract][Full Text] [Related]
14. Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo.
Fleury S; Simeoni E; Zuppinger C; Déglon N; von Segesser LK; Kappenberger L; Vassalli G
Circulation; 2003 May; 107(18):2375-82. PubMed ID: 12695294
[TBL] [Abstract][Full Text] [Related]
15. Lentiviral vector integration sites in human NOD/SCID repopulating cells.
Laufs S; Guenechea G; Gonzalez-Murillo A; Zsuzsanna Nagy K; Luz Lozano M; del Val C; Jonnakuty S; Hotz-Wagenblatt A; Jens Zeller W; Bueren JA; Fruehauf S
J Gene Med; 2006 Oct; 8(10):1197-207. PubMed ID: 16960916
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the Safety of Retroviral Vectors Based on Insertional Oncogene Activation and Blocked Differentiation in Cultured Thymocytes.
Zhou S; Fatima S; Ma Z; Wang YD; Lu T; Janke LJ; Du Y; Sorrentino BP
Mol Ther; 2016 Jun; 24(6):1090-1099. PubMed ID: 26957223
[TBL] [Abstract][Full Text] [Related]
17. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
Hacein-Bey-Abina S; Von Kalle C; Schmidt M; McCormack MP; Wulffraat N; Leboulch P; Lim A; Osborne CS; Pawliuk R; Morillon E; Sorensen R; Forster A; Fraser P; Cohen JI; de Saint Basile G; Alexander I; Wintergerst U; Frebourg T; Aurias A; Stoppa-Lyonnet D; Romana S; Radford-Weiss I; Gross F; Valensi F; Delabesse E; Macintyre E; Sigaux F; Soulier J; Leiva LE; Wissler M; Prinz C; Rabbitts TH; Le Deist F; Fischer A; Cavazzana-Calvo M
Science; 2003 Oct; 302(5644):415-9. PubMed ID: 14564000
[TBL] [Abstract][Full Text] [Related]
18. Lentivirus production is influenced by SV40 large T-antigen and chromosomal integration of the vector in HEK293 cells.
Gama-Norton L; Botezatu L; Herrmann S; Schweizer M; Alves PM; Hauser H; Wirth D
Hum Gene Ther; 2011 Oct; 22(10):1269-79. PubMed ID: 21554103
[TBL] [Abstract][Full Text] [Related]
19. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
Van Damme A; Chuah MK; Collen D; VandenDriessche T
Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930
[TBL] [Abstract][Full Text] [Related]
20. Use of nonintegrating lentiviral vectors for gene therapy.
Philpott NJ; Thrasher AJ
Hum Gene Ther; 2007 Jun; 18(6):483-9. PubMed ID: 17523890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
